1) Guilbert MC et al:Arterial trauma during central venous catheter insertion:case series, review and proposed algorithm. J Vasc Surg 48:918-25, 2008
Rad Fan 20/5 2022年5月号
目次
- 特集1 症例に学ぶVascular intervention
特集2 核医学Update 2021
～最新のSPECT解析と治療法～
特集1 症例に学ぶVascular intervention
序文
中心静脈カテーテルの動脈誤留置に対するIVR
Malperfusionを伴う大動脈解離に対する経皮的内膜開窓術
弓部大動脈瘤に対するin situ fenestrationを用いたTEVAR
破裂大動脈瘤に対するEVAR時の合併症
Bypass Graft吻合部狭窄に対する血管内治療
高度石灰化を伴う大腿膝窩動脈病変を攻略する。
Pave and CrackテクニックとPIERCEテクニック
腹腔動脈狭窄、上腸間膜動脈閉塞に起因する慢性腸間虚血に対し、
両方向性アプローチにて血行再建を施行した1例
特集2 核医学Update 2021
～最新のSPECT解析と治療法～
序文
心アミロイドーシスにおけるピロリン酸シンチグラフィの定量評価方法の進化
中世脂肪蓄積心筋血管症と123I-BMIPPの洗い出し率定量
神経内分泌腫瘍に対する177Lu-DOTATATE治療：ペプチド受容体放射性核種療法
骨SPECT/CTにおけるSUV測定の臨床応用
Deep Learningを応用した心筋血流SPECTの心外集積対処法
心筋SPECTの心外集積に対処する：cardioMUSK
連載 医療AIのチカラ
Vol.3 画像診断支援ソフトウェアEIRL、胸部領域における読影支援の現状と今後
連載 【MY BOOK MARK ～本当に使いやすい製品がこの中に～】
No.46 医療従事者に心身に優しい製品
連載 きっとyouも新しい仕事が見つかるかも！？【働き方ノート】
Vol.9
この書籍の参考文献
参考文献のリンクは、リンク先の都合等により正しく表示されない場合がありますので、あらかじめご了承下さい。
本参考文献は電子書籍掲載内容を元にしております。
【特集1 症例に学ぶVascular intervention】
P.17 掲載の参考文献
P.22 掲載の参考文献
1) 大動脈瘤・大動脈解離診療ガイドライン(2020年改訂版), 2020
2) 大場 匠ほか:下肢虚血を伴うB型急性大動脈解離に経皮的内膜開窓術を実施した1例. 臨床放射線 64(8):1079-83, 2019
3) 西巻 博:合併症を伴った急性大動脈解離に対する最近の治療戦略, 第47回日本IVR学会総会「技術教育セミナー」, 273-280, 2018
4) 西巻 博 ほか:ステントグラフトの大技小技. 183-185, メジカルビュー社, 2017
P.26 掲載の参考文献
1) Katada Y et al:Endovascular Total Arch Repair Usinga In Situ Fenestration for Arch Aneurysm and Chronic Type A Dissection. Ann Thorac Surg 101(2):625-630, 2016
2) Hongo N et al:"Squid-capture" modified in situ stent-graft fenestration technique for aortic arch aneurysm repair. Cardiovasc Intervent Radiol 37(4):1093-1098. 2014
3) Kopp R et al:Multicenter Analysis of Endovascular Aortic Arch In Situ Stent-Graft Fenestrations for Aortic Arch Pathologies. Ann Vasc Surg 59:36-47, 2019
P.30 掲載の参考文献
1) 循環器病の診断と治療に関するガイドライン 大動脈瘤・大動脈解離診療ガイドライン(2020年改訂版), 班長 荻野 均 日本循環器病学会
2) Koike Y et al:Sac angiography and glue embolization in emergency endovascular aneurysm repair for ruptured abdominal aortic aneurysm. Cardiovasc Intervent Radiol 38(2):457-462, 2015
3) Tsutsui M et al:A case of endovascular treatment for intestinal ischemia due to acute superior mesenteric artery embolism after TEVAR. J Surg Case Rep 2019(6):rjz185, 2019
4) S. D. Paatel et al:A shaggy aorta is associated with mesenteric embolisation in patients undergoing fenestrated endografts to treat paravisceral aortic aneurysms. Retroperitoneal hematoma volume is a good predictor of perioperative mortality after endovascular aneurysm repair for ruptured abdominal aortic aneurysm. Eur J Vasc Endovasc Surg 47(4):374-379, 2014
5) Fujimura N et al:Retroperitoneal hematoma volume is a good predictor of perioperative mortality after endovascular aneurysm repair for ruptured abdominal aortic aneurysm. J Vasc Surg 68(4):998-1006, 2018
P.34 掲載の参考文献
1) Airoldi F et al:Nitinol stents with polymerfree paclitaxel coating for stenosis of failing infrainguinal bypass grafts. J Cardiovasc Surg 54:441-445, 2013
2) Rosenthal D et al. Prosthetic above-knee femoropopliteal bypass for intermittent claudication. J Cardiovasc Surg 31(4):462-468, 1990
3) El-Massry S et al:Femoropopliteal bypass with externally supported knitted Dacron grafts:A follow-up of 200 grafts for one to twelve years. J Vasc Surg 19(3):487-494, 1994
4) Abbott W M et al:Prosthetic above-knee femoropopliteal bypass grafting:results of a multicenter randomized prospective trial. Above-Knee Femoropopliteal Study Group J Vasc Surg 25(1):19-28, 1997
5) Echave V et al:Intimal hyperplasia as a complication of the use of the polytetrafluoroethylene graft for femoral-popliteal bypass. Surgery 86(6):791-798, 1979
6) Sottiurai V S et al:Intimal hyperplasia and neointima:An ultrastructural analysis of thrombosed grafts in humans. Surgery 93(6):809-817, 1983
7) Cotroneo AR et al:Assisted patency with primary stent placement in distal anastomotic stenoses of lower limb bypass grafts. J Vasc Interv Radiol 18:25-30, 2007
8) 渋谷 卓 ほか:大腿膝窩動脈領域においてステント閉塞後に外科的治療を要した症例の検討. 脈管学 52(1):19-23, 2012
9) 磯田竜太郎 ほか:不適切な血管内治療で生じた重症虚血肢をバイパス術で救肢した1例. 日本血管外科学会雑誌 26:175-178, 2017
10) Midy D et al:A retrospective multicenter study of endovascular treatment of popliteal artery aneurysm. J Vasc Surg 51(4):850-856, 2010
11) Gerasimidis T et al:Endovascular treatment of popliteal artery aneurysms. Eur J Vasc Endovasc Surg 26(5):506-511, 2003
12) Boufi M et al:Emergency stent graft implantation for ruptured visceral artery pseudoaneurysm. J Vasc Surg;53(6):1625-1631, 2011
13) 田中克典:VIABAHNを留置した膝窩動脈瘤の1例. 日本血管外科学会雑誌 28(3):213-217, 2019
14) Fujimura N, Obara H, Iwasa K, et al. Preliminary experience of Viabahn stent graft inside the occluded prosthetic bypass graft for the treatment of above knee femoropopliteal bypass occlusion. Cardiovasc Intervent Radiol 43(2):223-230, 2020
P.38 掲載の参考文献
1) Dias-Neto M et al:Endovascular treatment of severely calcified femoropopliteal lesions using the "Pave-and-Crack" technique:technical description and 12-month results. J Endovasc Ther 25(3):334-342, 2018
2) Ichihashi S et al:Technique of percutaneous direct needle puncture of calcified plaque in the superficial femoral artery or tibial artery to facilitate balloon catheter passage and balloon dilation of calcified lesions. J Vasc Interv Radiol 25(5):784-8, 2014
P.42 掲載の参考文献
1) Bjorck M:Editor's Choice-Management of the Diseases of Mesenteric Arteries and Veins:Clinical Practice Guidelines of the European Society of Vascular Surgery (ESVS). Eur J Vasc Endovasc Surg 53:460-510, 2017
【特集2 核医学update2021～最新のSPECT解析と治療法～】
P.46 掲載の参考文献
1) Bokhari S et al:99mTc-pyrophosphate scintigraphy for differentiating light-chain cardiac amyloidosis from the transthyretinrelated familial and senile cardiac amyloidoses. Circ Cardiovasc Imaging 6(2):195-201, 2013
2) Castano A et al:Multicenter Study of Planar Technetium 99m Pyrophosphate Cardiac Imaging:Predicting Survival for Patients With ATTR Cardiac Amyloidosis. JAMA Cardiol 1(8):880-889, 2016
3) Dorbala S et al:Absolute Quantitation of Cardiac 99mTc-Pyrophosphate Using Cadmium-Zinc-Telluride-Based SPECT/CT. J Nucl Med 62(5):716-722, 2021
4) Watanabe S et al:Quantitative evaluation of 99mTc-pyrophosphate SPECT/CT in the diagnosis of transthyretin amyloid cardiomyopathy. J Nucl Med 61(s1):1607, 2020
5) Watanabe S et al:Volumetric evaluation of 99mTc-pyrophosphate SPECT/CT for transthyretin cardiac amyloidosis:Methodology and correlation with cardiac functional parameters. J Nucl Cardiol:online ahead of print, 2021
6) Miller RJH et al:Diagnostic and prognostic value of Technetium-99m pyrophosphate uptake quantitation for transthyretin cardiac amyloidosis. J Nucl Cardiol 28(2):1835-1845, 2021
7) Roshankar G et al:Quantitative technetium pyrophosphate and cardiovascular magnetic resonance in patients with suspected cardiac amyloidosis. J Nucl Cardiol:online ahead of print, 2021
8) Kyoungjune P et al:Prognostic value of metabolic tumor volume and total lesion glycolysis in head and neck cancer:a systematic review and meta-analysis. J Nucl Med 55(6):884-890, 2014
P.51 掲載の参考文献
1) Hirano K et al:Triglyceride deposit cardiomyovasculopathy. N Engl J Med 359(22):2396-8, 2008
2) Li M et al:Triglyceride deposit cardiomyovasculopathy:a rare cardiovascular disorder. Orphanet J Rare Dis 14(1):134, 2019
3) Hirano K:Triglyceride deposit cardiomyovasculopathy. Nihon Naika Gakkai Zasshi 106:2385-2390 (Article in Japanese), 2017
4) JCS 2018 Guideline for Diagnosis of Chronic Coronary Heart Diseases issued by Japan Circulation Society. https://wwwjcircorjp/cms/wpcontent/uploads/2020/02/JCS2018_yamagishi_tamakipdf.
5) Hosokawa R et al:Myocardial Metabolism of 123I-BMIPPin a Canine Model with Ischemia:Implications of Perfusion-Metabolism Mismatch on SPECT Images in Patients with Ischemie Heart Disease. J nucl Med 40(3):471-478, 1999
6) Kobayashi K et al:The Diagnostic Criteria 2020 for Triglyceride Deposit Cardiomyovasculopathy. Ann Nucl Cardiol 6(1):99-104, 2020
7) Hirano K et al:Increased Washout of 123I-BMIPP in Triglyceride Deposit Cardiomyovasculopathy (TGCV) with Severe Coronary Stenosis. Ann Nucl Cardiol 5(1):47-49, 2019
8) 厚生労働省 難治性疾患政策研究事業 TGCV研究班 中性脂肪蓄積心筋血管症 (TGCV)成果報告 2020年度版
9) Miyauchi H et al:Correlation Perspectives for the Diagnosis of Idiopathic Triglyceride Deposit Cardiomyovasculopathy. Ann Nucl Cardiol 6(1):33-8, 2020
10) Sakurabayashi T et al:Improvement of myocardial fatty acid metabolism through L-Carnitine administration to chronic hemodialysis patients. Am J Nephrol 19(4):480-84, 1999
P.55 掲載の参考文献
1) 細野 眞 ほか:医療における放射線防護と関連法令整備に関する研究:平成27年度総括・分担研究報告書:厚生労働科学研究費補助金研究報告書(地域医療基盤開発推進研究事業) http://jsnm.org/wp_jsnm/wp-content/themes/theme_jsnm/doc/Lu_houkokusho_manual_20160520.pdf
3) Strosberg JR et al:177Lu-Dotatate plus long-acting octreotide versus high-dose long-acting octreotide in patients with midgut neuroendocrine tumours (NETTER-1):final overall survival and long-term safety results from an openlabel, randomised, controlled, phase 3 trial. Lancet Oncol 22(12):1752-1763, 2021
4) Kobayashi N et al:Safety and efficacy of peptide receptor radionuclide therapy with 177Lu-DOTA0-Tyr3-octreotate in combination with amino acid solution infusion in Japanese patients with somatostatin receptor-positive, progressive neuroendocrine tumors. Ann Nucl Med 35(12):1332-1341, 2021
5) Bodei L et al:The joint IAEA, EANM, and SNMMI practical guidance on peptide receptor radionuclide therapy (PRRNT) in neuroendocrine tumours. Eur J Nucl Med Mol Imaging 40(5):800-816, 2013
6) Hope TA et al:NANETS/SNMMI Procedure Standard for Somatostatin Receptor-Based Peptide Receptor Radionuclide Therapy with 177Lu-DOTATATE. J Nucl Med 60(7):937-943, 2019
7) Lassmann M et al:Dosimetry for Radiopharmaceutical Therapy:The European Perspective. J Nucl Med 62:73S-79S, 2021
8) Kwekkeboom DJ et al:Radiolabeled somatostatin analog [177Lu-DOTA0, Tyr3] octreotate in patients with endocrine gastroenteropancreatic tumors. J Clin Oncol 23(12):2754-2762, 2005
9) Bergsma H et al:Subacute haematotoxicity after PRRT with (177)Lu-DOTA-octreotate:prognostic factors, incidence and course. Eur J Nucl Med Mol Imaging 43(3):453-463, 2016
10) Lemelin A et al:Elderly Patients with Metastatic Neuroendocrine Tumors Are Undertreated and Have Shorter Survival:The LyREMeNET Study. Neuroendocrinology 110(7-8):653-661, 2020
11) Ballal S et al:Broadening horizons with 225Ac-DOTATATE targeted alpha therapy for gastroenteropancreatic neuroendocrine tumour patients stable or refractory to 177Lu-DOTATATE PRRT:first clinical experience on the efficacy and safety. Eur J Nucl Med Mol Imaging 47(4):934-946, 2020
P.59 掲載の参考文献
1) Yamane T et al:Test-retest repeatability of quantitative bone SPECT/CT. Ann Nucl Med 35:338-46, 2021
2) Yamane T et al:Satisfied quantitative value can be acquired by short-time bone SPECT/CT using a whole-body cadmiumzinc-telluride gamma camera. Sci Rep 11:24320, 2021
3) Dennis ER et al:Bone scan index:a quantitative treatment response biomarker for castration-resistant metastatic prostate cancer. J Clin Oncol 30:519-24, 2012
4) Umeda T et al:Evaluation of bone metastatic burden by bone SPECT/CT in metastatic prostate cancer patients:defining threshold value for total bone uptake and assessment in radium-223 treated patients. Ann Nucl Med 32:105-13, 2018
5) Etchebehere EC et al:Prognostic Factors in Patients Treated with 223Ra:The Role of Skeletal Tumor Burden on Baseline 18F-Fluoride PET/CT in Predicting Overall Survival. J Nucl Med 56:1177-84, 2015
6) Yamane T et al:Quantification of osteoblastic activity in epiphyseal growth plates by quantitative bone SPECT/CT. Skeletal Radiol 47:805-10, 2018
7) Kuji I et al:Skeletal standardized uptake values obtained by quantitative SPECT/CT as an osteoblastic biomarker for the discrimination of active bone metastasis in prostate cancer. Eur J Hybrid Imaging 1:2, 2017
8) Kuji I et al:Lesion-specific Voxel-wise Absorbed Radiation Dose Estimation Of Bone Metastases In Patients With Prostate Cancer Using Quantitative Bone SPECT/CT Images. EANM2018. ＃E-PW023, 2018
9) Kuji I et al:Validation Of Diagnostic Accuracy Of Standardized Uptake Value (SUV) In Quantitative Skeletal SPECT/CT For Newly Diagnosed Patients With Bone Metastasis From Prostate Cancer. EANM2018. e-Poster#0607, 2018
P.63 掲載の参考文献
1) Hachamovitch R et al:Exercise myocardial perfusion SPECT in patients without known coronary artery disease:incremental prognostic value and use in risk stratification. Circulation 93:905-914, 1996
2) Sharir T et al:Prediction of myocardial infarction versus cardiac death by gated myocardial perfusion SPECT:risk stratification by the amount of stressinduced ischemia and the poststress ejection fraction. J Nucl Med 42:831-83, 2001
3) Nakajima K et al:Prediction of functional recovery after revascularization using quantitative gated myocardial perfusion SPECT:A multi-center cohort study in Japan. Eur J Nucl Med Mol Imaging 35:2038-2048, 2008
4) Hachamovitch R et al:Comparison of the short-term survival benefit associated with revascularization compared with medical therapy in patients with no prior coronary artery disease undergoing stress myocardial perfusion single photon emission computed tomography. Circulation 107:2900-2907, 2003
5) Francis J Klocke et al:ACC/AHA/ASNC guidelines for the clinical use of cardiac radionuclide imaging--executive summary:a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASNC Committee to Revise the 1995 Guidelines for the Clinical Use of Cardiac Radionuclide Imaging) J Am Coll Cardiol 42(7):1318-33, 2003
6) E. N. Heller et al:Extracardiac activity complicates quantitative cardiac SPECT imaging using a simultaneous transmissionemission approach, J. Nucl. Med38 (12):1882-1890, 1997
7) Hara M et al:Reduction of intracardiac intestinal activity by a small amount of soda water in technetium-99m tetrofosmin myocardial perfusion scintigraphy with adenosine stress. J Nucl Cardiol 15(2):241-5, 2008
8. Hajime Monzen et al:Exploring a technique for reducing the influence of scattered rays from surrounding organs to the heart during myocardial perfusion scintigraphy with technetium-99m sestamibi and technetium-99m tetrofosmin. Ann Nucl Med Dec 20(10):705-10, 2006
9) P.H. Pretorius, M. A. King, Spillover, compensation in the presence of respiratory motion embedded in SPECT perfusion data, IEEE Trans. Nucl. Sci. 55(1) 537-542, 2008 https://doi.org/10.1109/TNS.2007.912874. M. Vorster, M. M. Sathekge, P. Rheeder, Erythromycin as an alternative to reduce interfering extra-cardiac activity in myocardial perfusion imaging, Cardiovasc J Afr 21 (3) 142-147, 2010
10) Akihiro Kikuchi et al:A myocardial extraction method using deep learning for 99mTc myocardial perfusion SPECT images:A basic study to reduce the effects of extra-myocardial activity Computers in Biology and Medicine 141:105164, 2022
11) Siddique N. et al:U-Net and its variants for medical image segmentation:theory and applications, in IEEE Access, 9 82031-82057.
12) Zhou Z et al:UNet++:A nested U-Net architecture for medical image segmentation, International Workshop on Deep Learning in Medical Image Analysis and Multimodal Learning for Clinical Decision Support 3-11, 2018
P.68 掲載の参考文献
1) Burrell S et al:Artifacts and pitfalls in myocardial perfusion imaging. J Nucl Med Technol 34(4):193-211, 2006
2) 篠原広行 ほか:統計的な画像再構成の臨床応用への可能性. 日本医学放射線学会付録60(7):9-12, 2000
3) Segall G et al:Prone versus supine thallium myocardial SPECT:a method to decrease artifactual inferior wall defects. J Nucl Med 30(4):548-55, 1989
4) 小室敦司 ほか:99mTc心筋血流SPECTにおける横隔膜下高集積の影響を抑制する手法の考案ならびに画像再構成法を含めた有用性の検討. 核医学技術 41(4):431-441, 2021
5) EANM procedural guidelines for radionuclide myocardial perfusion imaging withSPECTandSPECT/CT(2015)2015_07_EANM_FINAL_myocardial_perfusion_guideline.pdf
6) 大西英雄 ほか:数値ファントムを用いた最新鋭 SPECTの位置分解能補正の基礎的検. 日本放射線技術学会雑誌68(6):686-696, 2012
【連載】
P.76 掲載の参考文献
1) 一般社団法人日本医療安全調査機構:栄養剤投与目的に行われた胃管挿入に係る死亡事例の分析. 医療事故の再発防止に向けた提言 2(6):2018
2) 松本純一 ほか:本当は教わりたかったポータブル胸部X線写真の読み方-サクッと読めて, ガツンとわかる7日間特別講義-. 23-70, メディカルサイエンスインターナショナル, 2019
3) 松本 學 ほか:病院職員の腰痛アンケート. 日本腰痛学会雑誌 7(1):73-78, 2001
4) 厚生労働省:職場における腰痛予防対策指針の改訂及びその普及に関する検討会報告書. 2013
最近チェックした商品履歴
Loading...